Proton beam therapy (PBT) has been shown to inhibit colon cancer metastasis by stimulating mitochondrial biogenesis through the upregulation of PGC-1α and its co-transcription factors (NRF1α/ERRα). Here, ESRRA is linked to malignant colon neoplasm.